FIBRIN FRAGMENT D-DIMER AND FIBRINOGEN-B-BETA PEPTIDES IN PLASMA AS MARKERS OF CLOT LYSIS DURING THROMBOLYTIC THERAPY IN ACUTE MYOCARDIAL-INFARCTION
Authors:
- EG BOVILLEBEG BOVILL
- DC STUMPDSDC STUMP
- DJ COLLENDCDJ COLLEN
- KG MANNKMKG MANN
- RP TRACYRTRP TRACY
- 1 October 1990
- journal article
- research article
- Vol. 76 (7) , 1341-1348
Abstract
The validity of markers in plasma of in vitro thrombolysis was investigated in 12 patients with extensive fibrinogen breakdown (>80%, group 1) and in 12 patients with minimal breakdown (<20%, group 2). The patients were treated with 100 mg of recombinant tissue-type plasminogen activator (rt-PA) in the "Thrombolysis in Myocardial Infarction II" (TIMI II) trial. Cross-linked fibrin degradation product levels were measured with two variant enzyme-linked immunosorbent assays (ELISAs), both using a fibrin fragment D-dimer specific capture antibody. In one instance, a tag antibody was used that cross-reacts with fibrinogen (pan-specific tag ELISA); in the other, the tag antibody was specific for fibrin fragment D (fibrin-specific tag ELISA). Apparent concentrations of cross-linked fibrin degradation products at baseline were within normal limits with both assays in most patients. At 8 hours after rt-PA products were increased about twofold to fourfold in group 2 with both assays. However, in group 1, levels were significantly higher with the pan-specific tag ELISA (5.8 .+-. 4.2 .mu.g/mL) compared with the fibrin-specific tag ELISA (1.5 .+-. 1.3 .mu.g/mL). This observation was most likely a result of detection of fibrinogen degradation products in the pan-specific ELISA. Apparent levels of fibrinopeptide B.beta.1-42, a marker of fragment X formation, increased during thrombolysis from 4.2 .+-. 2.8 pmol/mL to 2,000 .+-. 230 pmol/mL in group 1 and from 4.1 .+-. 2.1 pmol/mL to 300 .+-. 43 pmol/mL in group 2, and were correlated significantly with the extent of fibrinogen breakdown (r = -0.8). Fibrinopeptide .beta.15-42 levels increased from 4.3 .+-. 3 pmol/mL to 70 .+-. 19 pmol/mL in group 1, but did not increase in group 2. The apparent increase in group 1 could be explained by cross-reactivity of fibrinopeptide B.beta.1-42 in the fibrinopeptide .beta.15-42 assay. We conclude that cross-linked fibrin degradation product levels as measured with a pan-specific tag ELISA and fibrinopeptide .beta.15-42 levels as measured with certain monoclonal antibody-based ELISA are influenced by the extent of fibrinogen degradation. Fibrinopeptide B.beta.1-42 is a marker specific for fibrinogen breakdown. Cross-linked fibrin degradation product levels, measured with a fibrin-specific tag ELISA, appear to be markers specific for thrombolysis. Consequently, assays similar to the fibrin-specific tag ELISA may provide more accurate information when correlated with clinical endpoints.Keywords
This publication has 26 references indexed in Scilit:
- DEVELOPMENT OF A RADIOIMMUNOASSAY FOR THE FIBRINOGEN-DERIVED PEPTIDE B-BETA-1-421986
- Analysis of coagulation and fibrinolysis during intravenous infusion of recombinant human tissue-type plasminogen activator in patients with acute myocardial infarction.Circulation, 1986
- Factor VIII antibody in a patient with mild haemophiliaBritish Journal of Haematology, 1985
- Assay of Human Tissue-Type Plasminogen Activator (t-PA) with an Enzyme-Linked Immunosorbent Assay (ELISA) Based on Three Murine Monoclonal Antibodies to t-PAThrombosis and Haemostasis, 1985
- Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial.Circulation, 1984
- Specificity of a monoclonal antibody for the NH2-terminal region of fibrinMolecular Immunology, 1984
- A monoclonal antibody with ability to distinguish between NH2-terminal fragments derived from fibrinogen and fibrinMolecular Immunology, 1983
- Measurement of Crosslinked Fibrin Degradation Products – An Immunoassay Using Monoclonal AntibodiesThrombosis and Haemostasis, 1983
- Characterization of the inhibition of fibrin assembly by fibrinogen fragment DBiochemical Journal, 1981
- Early events in the plasmin digestion of fibrinogen and fibrin. Effects of plasmin on fibrin polymerization.Journal of Biological Chemistry, 1977